{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(7)"],"submitter":["Tanguy-Melac A"],"pubmed_abstract":["<h4>Background</h4>Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature.<h4>Objective</h4>To describe monthly reimbursed expenditure during the last year of life among cancer patients, by performing detailed analysis according to type of expenditure and the person's age.<h4>Method</h4>Data were derived from the Système national des données en santé (SNDS) [national health data system], which comprises information on ambulatory and hospital care. Analyses focused on general scheme beneficiaries (77% of the French population) treated for cancer who died in 2015.<h4>Results</h4>Average reimbursed expenditure during the last year of life was €34,300 per person in 2015"],"journal":["The European journal of health economics : HEPAC : health economics in prevention and care"],"pagination":["1039-1052"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8318964"],"repository":["biostudies-literature"],"pubmed_title":["Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study."],"pmcid":["PMC8318964"],"pubmed_authors":["Tuppin P","Gastaldi-Menager C","Pestel L","Fagot-Campagna A","Tanguy-Melac A","Verboux D"],"additional_accession":[]},"is_claimable":false,"name":"Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study.","description":"<h4>Background</h4>Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature.<h4>Objective</h4>To describe monthly reimbursed expenditure during the last year of life among cancer patients, by performing detailed analysis according to type of expenditure and the person's age.<h4>Method</h4>Data were derived from the Système national des données en santé (SNDS) [national health data system], which comprises information on ambulatory and hospital care. Analyses focused on general scheme beneficiaries (77% of the French population) treated for cancer who died in 2015.<h4>Results</h4>Average reimbursed expenditure during the last year of life was €34,300 per person in 2015","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2025-05-29T20:47:30.052Z","creation":"2025-05-29T20:47:30.052Z"},"accession":"S-EPMC8318964","cross_references":{"pubmed":["34100171"],"doi":["10.1007/s10198-021-01304-1"]}}